Zymeworks Inc. Files Q1 2025 10-Q Report
Ticker: ZYME · Form: 10-Q · Filed: May 8, 2025 · CIK: 1937653
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
**Zymeworks Q1 2025 10-Q filed. Financials updated.**
AI Summary
Zymeworks Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position and operational activities during the first quarter of 2025. Key financial data and disclosures relevant to investors are included.
Why It Matters
This 10-Q filing provides investors with an update on Zymeworks' financial health and operational progress for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Zymeworks faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Zymeworks Inc. (company) — Filer of the 10-Q report.
- 20250331 (date) — Conformed period of report.
- 20250508 (date) — Filed as of date.
- 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709 (address) — Company's business and mail address.
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is 20250331, meaning the filing covers the first quarter of 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed as of date 20250508.
What is Zymeworks Inc.'s primary business address?
Zymeworks Inc.'s business address is 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709.
What was Zymeworks Inc.'s former company name?
Zymeworks Inc.'s former company name was Zymeworks Delaware Inc.
On what date did Zymeworks Inc. change its name?
The date of the name change was 20220712.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Zymeworks Inc. (ZYME).